Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes
Clinical trial NCT01968265 · COMPLETED
Trial details
- NCT number
- NCT01968265
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.